At the European Society for Thoracic Surgeons (ESTS) 2023 Conference, Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA, and Francesco Grossi, Medical Oncology Division, University of Insubria, Varese, Italy, shared their perspectives on the future of immunotherapies and practical considerations in resectable non-small cell lung cancer (NSCLC) using a patient case.
This symposium was developed and funded by the medical department of Bristol Myers Squibb.
